Chimeric Antigen Receptors
Medicine & Life Sciences
100%
T-Lymphocytes
Medicine & Life Sciences
71%
Stomach Neoplasms
Medicine & Life Sciences
67%
Geminin
Medicine & Life Sciences
66%
B-Cell Lymphoma
Medicine & Life Sciences
65%
ADP-ribosyl Cyclase 1
Medicine & Life Sciences
64%
Cell Line
Medicine & Life Sciences
63%
Plasma Cells
Medicine & Life Sciences
62%
Hara, T. ,
Tominaga, Y. ,
Ueda, K. ,
Mihara, K. ,
Yanagihara, K. &
Takei, Y. ,
07-2022 ,
In: Biochemistry and Biophysics Reports. 30 , 101255.
研究成果: Article › 査読
Methyltransferases
100%
Stomach Neoplasms
77%
Small Interfering RNA
41%
Protein
37%
Modification
16%
Murayama, Y. ,
Kawashima, H. ,
Kubo, N. ,
Shin, C. ,
Kasahara, Y. ,
Imamura, M. ,
Oike, N. ,
Ariizumi, T. ,
Saitoh, A. ,
Mihara, K. ,
Umezu, H. ,
Ogose, A. &
Imai, C. ,
12-2021 ,
In: Translational Oncology. 14 ,
12 , 101227.
研究成果: Article › 査読
Chimeric Antigen Receptors
100%
Synovial Sarcoma
99%
human ERBB2 protein
90%
Cell- and Tissue-Based Therapy
70%
T-Lymphocytes
45%
Mizuno, N. ,
Kume, K. ,
Nagatani, Y. ,
Matsuda, S. ,
Iwata, T. ,
Ouhara, K. ,
Kajiya, M. ,
Takeda, K. ,
Matsuda, Y. ,
Tada, Y. ,
Ohsawa, R. ,
Morino, H. ,
Mihara, K. ,
Fujita, T. ,
Kawaguchi, H. ,
Shiba, H. ,
Kawakami, H. &
Kurihara, H. ,
01-10-2020 ,
In: Journal of Human Genetics. 65 ,
10 ,
p. 841-846 6 p. 研究成果: Article › 査読
Aggressive Periodontitis
100%
Protein Domains
72%
Nucleotides
57%
Crohn Disease
22%
Caspase Activation and Recruitment Domain
17%
Kasahara, Y. ,
Shin, C. ,
Kubo, N. ,
Mihara, K. ,
Iwabuchi, H. ,
Takachi, T. ,
Imamura, M. ,
Saitoh, A. &
Imai, C. ,
01-2020 ,
In: Clinical and Translational Immunology. 9 ,
7 , e1147.
研究成果: Article › 査読
Chimeric Antigen Receptors
100%
Natural Killer Cells
68%
T-Lymphocytes
45%
Neoplasms
12%
bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine
10%
Takei, Y. ,
Hara, T. ,
Suzuki, A. ,
Mihara, K. &
Yanagihara, K. ,
11-2020 ,
In: Pathobiology. 87 ,
5 ,
p. 277-290 14 p. 研究成果: Article › 査読
Antisense RNA
100%
Epithelial-Mesenchymal Transition
80%
Stomach Neoplasms
67%
RNA
53%
Zinc Finger E-box-Binding Homeobox 1
50%